Brainstorm Cell Therapeutics
Why Robinhood?
You can watch BCLI and buy or sell other stocks, ETFs, and their options commission-free!About BCLI
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function.
BCLI Key Statistics
Stock Snapshot
The current Brainstorm Cell Therapeutics(BCLI) stock price is $0.73, with a market capitalization of 58.84M. The stock trades at a price-to-earnings (P/E) ratio of -15.25.
During the trading session on 2026-03-10, Brainstorm Cell Therapeutics(BCLI) shares reached a daily high of $0.73 and a low of $0.63. At a current price of $0.73, the stock is +15.8% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 35.32K, compared to an average daily volume of 385.89K.
Over the past 52 weeks, Brainstorm Cell Therapeutics(BCLI) stock has traded between a high of $0.79 and a low of $0.13.
Over the past 52 weeks, Brainstorm Cell Therapeutics(BCLI) stock has traded between a high of $0.79 and a low of $0.13.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.